Hypertension, sleep and obstructive sleep apnea

Česká verzia

Authors: Sovová E.1 ^,2; Marek Sova ³ ; M. Hobzová ³; V. Kolek ³
Authors place of work: I. Interní klinika- kardiologická, Lékařská fakulta UP v Olomouci, Fakultní nemocnice Olomouc, Přednosta: doc. MUDr. Miloš Táborský, CSc., MBA. ¹; Klinika tělovýchovného lékařství a kardiovaskulární rehabilitace, Lékařská fakulta UP v Olomouci, Fakultní nemocnice Olomouc, Přednostka: doc. MUDr. Eliška Sovová, Ph. D., MBA. ²; Klinika plicních nemocí a tuberkulózy, Lékařská fakulta UP v Olomouci, Fakultní nemocnice Olomouc Přednosta: prof. MUDr. Vítězslav Kolek, DrSc. ³
Published in the journal: Prakt. Lék. 2012; 92(6): 327-329
Category: Various Specialization

Summary

Obstructive sleep apnea (OSA) is a very common disease that carries with it a lot of risk factors that influence patient’s morbidity and mortality. Hypertension is a significant risk factor for cardiovascular diseases, and OSA is an independent risk factor for hypertension. In some patients there is a lack of night time blood pressure decrease, which can worsen their prognosis. OSA is often the cause of resistant hypertension. The treatment of OSA with a continuous positive airway pressure ventilator demonstrably improves OSA parameters but it’s impact on compensation of hypertension is controversial. In hypertensive OSA patients, the increase of plasmatic aldosterone level is common and it is likely that these patients could benefit from pharmacological treatment with spironolactone.

Key words:
Obstructive sleep apnea, hypertension, continuous airway pressure

Zdroje

1. Alajmi, M., Mulgrew, A.T., Fox J. et al. Impact of continous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnoea: a meta analysis of randomized controlled trials. Lung, 2000, 185, p. 67–72.

2. Baquet, J.P., Barone-Rochette, G., Pépin J.L. Hypertension and obstructive sleep apnoea syndrome: current perspectives. J Hum Hypertension, 2009, 23, p. 431–443.

3. Bazzano, L.A., Khan, Z., Reynolds, K., He J. Effect of nocturnal nasal continous positive airway pressure on blood pressure in obstructive sleep apnoea. Hypertension, 2007, 50, p. 4174–423.

4. Bradley, T.G., Floras, J.S. Obstructive sleep apnoea and its cardiovascular consequences. Lancet, 2009, 373, p. 82–93.

5. Calhoun, D.A., Harding, S.M. Sleep and hypertension. Chest, 2010, 138, p. 434–443.

6. Calhoun, D.A., Jones, D., Textor, S. et al. Resistant hypertension: diagnosis, evaluation and treatment. A scientific statement from the American Heart Association professional education committee of the council for high blood pressure research. Hypertension, 2008, 51, p. 1403–1419.

7. Cappuccio, F.P., Cooper, D., D´Elia, L. et al. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J, 2011, 32, p. 1484–1492.

8. Gaddam, K., Pimenta, E., Thomas, S.J. Spironolactone reduces severity of obstructive sleep apnea in patients with resistant hypertension: a preliminary report. J Hum Hypertens, 2009, 24, p. 532–537.

9. Gangwisch, J.E., Heymsfield, S.B., Boden-Albala, B. Short sleep duration as a risk faktor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension, 2006, 47, p. 833–839.

10. Gonzaga, C.C., Gaddam, K.K., Ahmed, M.I. et al. Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. J Clin Sleep Med, 2010, 6, p. 363–368.

11. Gottlieb, D.J., Redline, S., Nieto, F.J. et al. Association of unusual sleep duration with hypertension: the Sleep Hearth Health Study. Sleep, 2006, 29, p. 1009–1014.

12. Haentjens, P., Van Meerhaeghe, A., Moscariello, A. et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta analysis of placebo controlled randomized trials. Arch Intern Med, 2007, 167, p. 757–764.

13. Issa F.G. Effect of clonidine in obstructive sleep apnea. Am Rev Respir Dis, 1992, 145, p. 435–439.

14. Knutson, K.L., Turek, F.W. The U-shaped association between sleep and health: the 2 peaks do not mean the same thing. Sleep, 2006, 29, p. 878–879.

15. Kraiczi, H., Hedner, J., Peker, Y., Grote, L. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med, 2000, 161, p. 1423–1428.

16. Lavie, P., Herer, P., Hoffstein, V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ, 2000, 320, p. 479–482.

17. Law, M.R., Morris, J.K., Wald, N.J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectation from prospective epidemiological studies. BMJ, 2009, 338, p. 1245–1253.

18. Logan, A.G., Perlikowski, S.M., Mente, A. et al. High prevalence of unrecognised sleep apnoea in drug resistant hypertension. J Hypertens, 2001, 19, p. 2271-2277.

19. Mo, L., He, Q.Y. Effect of long term continuous positive airway pressure ventilation on blood pressure in patients with obstructive sleep apnea hypopnea syndrome: a meta analysis of clinical trials. Zhonghua Yi Xue Za Zhi, 2007, 87, p. 1177–1180.

20. Moráň, M., Kadaňka, Z., Blatný, M. Kvalita spánku u pacientů se syndromem spánkové apnoe a její ovlivnění léčbou trvalým přetlakem, vztah k hypertenzní chorobě. Česk Slov Neurol N, 2000, 63, s. 209–214.

21. Nevšímalová S., Šonka K. Poruchy spánku a bdění. 2. vydání. Praha: Galén, 2007. 345 s.

22. Nieto, F.J., Young, T.B., Lind, B.K. et al. Association of sleep- disorderes breathing, sleep apnea and hypertension in a large community-based study. JAMA, 2000, 283, p. 1829-1836.

23. Ohkubo, T., Hozawa, A., Nagai, K. et al. Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in general population: the Ohasama study. J Hypertens, 2000, 18, p. 847–854.

24. Parati G., Lombardi C., Hedner J. et al. Position paper on the management of patients with obstructive sleep apnea and hypertension: Joint recommendations by the European Society and by the members of European COST (Cooperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea. J Hypertens, 2012, 30, p.633–646.

25. Peppard, P.E., Young, T., Palta, M., Skatrud, J. Prospective study of the association between sleep- disordered breathing and hypertension. N Engl J Med, 2000, 342, p. 1378–1384.

26. Somers, V.K., White, D.P., Amin, R. et al. Sleep apnea and cardiovascular disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Commitee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing In Collaboration With the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institute of Health). J Am Coll Cardiol, 2008, 52, p. 686–717.

27. Šonka, K., Slonková, J. Spánková apnoe dospělého věku. Česk Slov Neurol N 2008, 71/104, č. 6, s. 643–656.

28. Šonka K. Poruchy dýchání vázané na spánek u dospělých. Prakt Lék 2007, 87, č. 6, s. 319–327.

29. Young, T., Palta, M., Dempsey, J. et al. The occurence of sleep disordered breathing among middle aged adults. N Engl J Med, 1993, 328, p. 1230–1235.

30. Young, T., Peppard, P., Palta, M. et al. Population based study of sleep disordered breathing as a risk faktor for hypertension. Arch Intern Med, 1997, 157, p. 1746–1752.